Mastitis therapy and pharmacology

Veterinary Clinics of North America - Food Animal Practice

Volumn 19, Issue 1, 2003, Pages 109-138

  Erskine, Ronald J ^a   Wagner, Sarah ^b   DeGraves, Fred J ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CARPROFEN; CEFALOTIN; CEFTIOFUR; DEXAMETHASONE; DIPYRONE; ERYTHROMYCIN; FLUNIXIN MEGLUMINE; FLURBIPROFEN; GENTAMICIN; IBUPROFEN; ISOFLUPREDONE; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORDIHYDROGUAIARETIC ACID; PENICILLIN G; PHENYLBUTAZONE; PIRLIMYCIN; STEROID; SULFATRIMETHOPRIM; TETRACYCLINE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT;

ANTIBIOTIC SENSITIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; INFECTION PREVENTION; MASTITIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REVIEW; VETERINARY MEDICINE; ANIMAL; CATTLE; CATTLE DISEASE; CYTOLOGY; DOSE RESPONSE; FEMALE; MICROBIOLOGY; MILK; STANDARD; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS);

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MASTITIS, BOVINE; MILK; TREATMENT OUTCOME;

EID: 2442581330     PISSN: 07490720     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0720(02)00067-1     Document Type: Review

References (72)

1. Bartlett P.C., Van Wijk J., Wilson D.J., et al. Temporal patterns of lost milk production following clinical mastitis in a large dairy herd. J Dairy Sci. 74:1991;1561-1572
2. Hoblet K.H., Schnitkey G.D., Arbaugh D., et al. Costs associated with selected preventive practices and episodes of clinical mastitis in nine herds with low somatic cell counts. J Am Vet Med Assoc. 199:1991;190-196
3. Sears P.M., English P.B., Dinsmore R.P., et al. Isolation of L-form variants after antibiotic treatment in Staphylococcus aureus bovine mastitis. J Am Vet Med Assoc. 191:1987;681-686
4. Erskine R.J., Eberhart R.J., Spencer S.B. Pseudomonas mastitis: difficulties in detection and elimination from contaminated wash-water systems. J Am Vet Med Assoc. 191:1987;811-815
5. Newbould F.H.S. Antibiotic treatment of experimental Staphylococcus aureus infections of the bovine mammary gland. Can J Comp Med. 38:1974;411-416
6. Sears P.M., Smith B.S., English P.B., et al. Shedding patterns of Staphylococcus aureus from bovine intramammary infections. J Dairy Sci. 73:1990;2785-2789
7. Ziv G. Practical pharmacokinetic aspects of mastitis therapy - 2. Practical and therapeutic applications. Agri Practice. March:1980;469-476
8. Owens W.E., Watts J.L., Boddie R.L., et al. Antibiotic treatment of mastitis: comparison of intramammary and intramammary plus intramuscular therapies. J Dairy Sci. 71:1988;3143-3147
9. Sol J., Harink J., van Uum A. Factors affecting the result of dry cow treatment. Proceedings of the International Symposium on Bovine Mastitis. 1990;118-123 National Mastitis Council, Madison (WI)
10. Shpigel N.Y., Chen R., Winkler M., et al. Anti-inflammatory ketoprofen in the treatment of field cases of bovine mastitis. Res Vet Sci. 56:(1):1994;62-68
11. Cebra C.K., Garry F.B., Dinsmore R.P. Naturally occurring acute coliform mastitis in Holstein cattle. J Vet Int Med. 10:1996;252-257
12. Erskine R.J., Bartlett P.C., Van Lente J., et al. Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle. J Dairy Sci. 85:2002;2571-2575
13. Morin D., Shanks R.D., McCoy G.C., et al. Comparison of antibiotic administration in conjunction with supportive measures versus supportive measures alone for treatment of dairy cows with clinical mastitis. J Am Vet Med Assoc. 213:1988;676-681
14. Wenz J.R., Barrington G.M., Garry F.B., et al. Bacteremia associated with naturally occurring acute coliform mastitis in dairy cows. J Am Vet Med Assoc. 219:2001;976-981
15. Prescott J.F., Walker R.D. Principles of antimicrobial drug selection and use. Prescott J.F., Baggot C.A., Walker R.D. Antimicrobial therapy in veterinary medicine. 3rd edition :2000;88-98 Iowa State University Press, Ames (IA)
16. Anderson K.L., Smith A.R., Gustaffson B.K., et al. Diagnosis and treatment of acute mastitis in a large dairy herd. J Am Vet Med Assoc. 181:1982;690-693
17. Anderson K.L. Therapy for acute coliform mastitis. Comp Cont Ed Pract Vet. 11:1989;1125-1133
18. Erskine R.J., Tyler J.W., DeGraves F.J., et al. Advances in the therapy of mastitis. Vet Clin N Am. 9:1993;499-526
19. Burton J.L., Kehrli M.E. Jr. Regulation of neutrophil adhesion molecules and shedding of Staphylococcus aureus in milk of cortisol- and dexamethasone-treated cows. Am J Vet Res. 56:1995;997-1006
20. Kerhli M.E. Jr., Nonnecke B.J., Roth J.A. Alterations in bovine neutrophil function during the periparturient period. Am J Vet Res. 50:1989;207-214
21. Jones G.F., Ward G.E. Evaluation of systemic administration of gentamicin for treatment of coliform mastitis in cows. J Am Vet Med Assoc. 197:1990;731-736
22. Erskine R.J., Wilson R.C., Riddell M.G., et al. Intramammary gentamicin as a therapy for experimental Escherichia coli mastitis. J Am Vet Med Assoc. 53:1992;375-381
23. Pyorala S., Kaartinen S., Kack H., et al. Efficacy of two therapy regimens for treatment of experimentally induced Escherichia coli mastitis in cows. J Dairy Sci. 77:1994;453-461
24. Shpigel N.Y., Levin D., Winkler M., et al. Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. J Dairy Sci. 80:1997;318-323
25. Erskine R.J., Tyler J.W., Wilson R.C., et al. Ceftiofur distribution in serum and milk from clinically normal cows and cows with experimental Escherichia coli-induced mastitis. Am J Vet Res. 56:1995;481-485
26. Owens W.E., Xiang Z.Y., Ray C.H., et al. Determination of milk and mammary tissue concentrations of ceftiofur after intramammary and intramuscular therapy. J Dairy Sci. 73:1990;3449-3456
27. Wilson C.D., Agger N., Gilbert G.A., et al. Field trials with cefaperazone in the treatment of bovine clinical mastitis. Vet Rec. 118:1986;17-22
28. Wilson D.J., Gonzalez R.N., Case K.L., et al. Comparison of seven antibiotic treatments with no treatment for bacteriologic efficacy against bovine mastitis pathogens. J Dairy Sci. 82:1999;1664-1670
29. Guterbock W.M., Van Eenennaam A.L., Anderson R.J., et al. Efficacy of intramammary antibiotic therapy for treatment of clinical mastitis caused by environmental pathogens. J Dairy Sci. 76:1993;3437-3444
30. Van Eeenanaam A.L., Gardner I.A., Holmes J., et al. Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens. J Dairy Sci. 78:1995;2086-2095
31. Cattell M.B. An outbreak of Streptococcus uberis as a consequence of adopting a protocol of no antibiotic therapy for clinical mastitis. Proceedings of the 35th Annual Meeting of the National Mastitis Council, Nashville, TN. 1996;123-130 National Mastitis Council, Madison (WI)
32. Hillerton J.E., Semmens J.E. Comparison of treatment of mastitis by oxytocin or antibiotics following detection according to changes in milk electrical conductivity prior to visible signs. J Dairy Sci. 82:1999;93-98
33. Hillerton J.E., Kliem K.E. Aggressive therapy of clinical Streptococcus uberis mastitis. The 2nd International Symposium on Mastitis and Milk Quality. 2001;234-237 American Association of Bovine Practitioners, Vancouver; Rome (GA)
34. Pyorala S., Taponen S., Dredge K., et al. Efficacy of intramammary treatment with procaine penicillin G vs procaine penicillin G plus neomycin in bovine clinical mastitis: a double blind field study. The 2nd International Symposium on Mastitis and Milk Quality, Vancouver. 2001;219-223 American Association of Bovine Practitioners, Rome (GA)
35. Owens W.E., Ray C.H., Watts J.L., et al. Comparison of success of antibiotic therapy during lactation and results of antibacterial susceptibility tests for bovine mastitis. J Dairy Sci. 80:1997;313-317
36. Erskine R.J., Eberhart R.J. Herd benefit-to-cost ratio and effects of a bovine mastitis control program that includes blitz treatment of Streptococcus agalactiae. J Am Vet Med Assoc. 196:1990;1230-1235
37. Yamagata M., Goodger W.J., Weaver L., et al. The economic benefit of treating subclinical Streptococcus agalactiae mastitis in lactating cows. J Am Vet Med Assoc. 191:1987;1556-1561
38. Erskine R.J., Bartlett P.C., Johnson G.L. II, et al. Intramuscular administration of ceftiofur sodium versus intramammary infusion of penicillin/novobiocin for treatment of Streptococcus agalactiae mastitis in dairy cows. J Am Vet Med Assoc. 208:1996;258-260
39. Weaver L.D., Galland J., Martin P.A.J., et al. Treatment of Streptococcus agalactiae mastitis in dairy cows: comparative efficacies of two antibiotic preparations and factors associated with successful treatment. J Am Vet Med Assoc. 189:1986;666-669
40. Ziv G., Storper M. Intramuscular treatment of subclinical staphylococcal mastitis in lactating cows with penicillin G, methicillin and their esters. J Vet Pharm Therap. 8:1985;276-282
41. Soback S., Adler H., Van Damm B., et al. Systemic dry cow therapy in control of subclinical Staphylococcus aureus infections. Proceedings of the International Symposium on Bovine Mastitis, Indianapolis, IN. 1990;134-137 National Mastitis Council, Madison (WI)
42. Erskine R.J., Bartlett P.C., Crawshaw P.C., et al. Efficacy of intramuscular oxytetracycline as a treatment for Staphylococcus aureus mastitis. J Dairy Sci. 77:1994;3347-3353
43. Sordillo L.M., Peel J., Babiuk L.A. Potential role of cytokines in determining the outcome of acute coliform mastitis. Proceedings of the 30th Annual Meeting of the National Mastitis Council, Arlington, VA. 1991;51-58 National Mastitis Council, Madison (WI)
44. Daley M.J., Coyle P.A., Williams T.J., et al. Staphylococcus aureus mastitis: pathogenesis and treatment with bovine interleukin-1β and interleukin-2. J Dairy Sci. 74:1991;4413-4424
45. Daley M.J., Oldham E.R., Williams T.J., et al. Quantitative and qualitative properties of host polymorphonuclear cells during experimentally induced Staphylococcus aureus mastitis in cows. Am J Vet Res. 52:1991;474-480
46. Erskine R.J., Bartlett P.C., Tavernier S., et al. Recombinant bovine interleukin-2 and dry cow therapy: efficacy to cure and prevent intramammary infections, safety, and effect on gestation. J Dairy Sci. 81:1998;107-115
47. Hogan J.S., Smith K.L., Todhunter D.A., et al. Efficacy of recombinant bovine interleukin-2 as an adjunct to dry cow therapy. J Dairy Sci. 78:1995;1062-1067
48. Roberson J.R., Fox L.K., Hancock D.D., et al. Sources of intramammary infections from Staphylococcus aureus in dairy heifers at first parturition. J Dairy Sci. 81:1998;687-693
49. Owens W.E., Oliver S.P., Gillespie B.E., et al. Role of horn flies (Haematobia irritans) in Staphylococcus aureus-induced mastitis in dairy heifers. Am J Vet Res. 59:1998;1122-1124
50. Oliver S.P., Lewis M.J., Gillespie B.E., et al. Influence of prepartum antibiotic therapy on intramammary infections in primigravid heifers during early lactation. J Dairy Sci. 75:1992;406-414
51. Oliver S.P., Lewis M.J., Gillespie B.E., et al. Antibiotic residues and prevalence of mastitis pathogen isolation in heifers during early lactation following prepartum antibiotic therapy. Zentralbl Veterinarmed. 44:1997;213-220
52. Adams R.H. Glucocorticoids, mineralocorticoids, and steroid synthesis inhibitors. Veterinary pharmacology and therapeutics. 2001;229-267 Iowa State University Press, Ames (IA)
53. Hirata F. Lipomodulin: a possible mediator of the action of glucocorticoids. Adv Prostaglandin Thromboxane Leukot Res. 11:1983;73-82
54. Lohuis J.A., Van Leeuwen W., Verheijden J.H.M., et al. Effect of dexamethasone on experimental Escherichia coli mastitis in the cow. J Dairy Sci. 71:1988;2782-2789
55. Anderson K.L., Hunt E. Anti-inflammatory therapy in acute endotoxin-induced bovine mastitis. Vet Res Commun. 13:1989;17-26
56. Lohuis J.A., Van Leeuwen W., Verheijden J.H.M., et al. Effect of steroidal anti-inflammatory drugs on Escherichia coli endotoxin-induced mastitis in the cow. J Dairy Sci. 72:1989;241-249
57. Burton J.L., Kehrli M.E. Jr., Kapil S., et al. Regulation of L-selectin and CD18 on bovine neutrophils by glucocorticoids: effects of cortisol and dexamethasone. J Leuk Biol. 57:1995;317-325
58. Preisler M.T., Weber P.S.D., Templeman R.J., et al. Glucocorticoid receptor down-regulation in neutrophils of peripartuirent cows. Am J Vet Res. 61:2000;14-19
59. Hill A.W., Shears A.L., Hibbitt K.G. The pathogenesis of experimental Escherichia coli mastitis in newly calved dairy cows. Res Vet Sci. 26:1979;97-101
60. Anderson K.L., Hunt E., Davis B.J. The influence of anti-inflammatory therapy on bacterial clearance following intramammary Escherichia coli challenge in goats. Vet Res Commun. 15:(2):1991;147-161
61. Erskine R.J., Eberhart R.J., Grasso P.J., et al. Induction of Escherichia coli mastitis in cows fed selenium-deficient or selenium-supplemented diets. Am J Vet Res. 50:1989;2093-2100
62. Aruoma O.I., Halliwell B. The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugs. Xenobiotica. 18:1988;459-467
63. Dawson W., Boot J.R., Harvey J., et al. The pharmacology of benoxaprofen with particular reference to effects of lipoxygenase products formation. Eur J Rheumatol Inflamm. 5:1982;61-66
64. Hiller K.O., Willson R.L. Hydroxyl-free radicals and anti-inflammatory drugs: biological inactivation studies and reaction rate constants. Biochem Pharmmacol. 32:1983;2109-2115
65. Migne J., Vedrine Y., Bourat G., et al. Action of ketoprofen on hepatic lysosomes in rats. Rheumatol Rehabil. 15:1976;15-19
66. Brune K. Is there a rational basis for the different spectra of adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs)? Drugs. 40:1990;12-19
67. Kopcha M., Kaneene J.B., Shea M.E., et al. Use of nonsteroidal anti-inflammatory drugs in food animal practice. J Am Vet Med Assoc. 201:1992;1868-1872
68. DeGraves F.J., Anderson K.L. Ibuprofen treatment of endotoxin-induced bovine mastitis. Am J Vet Res. 54:1993;1128-1132
69. Lohuis J.A., van Werven T., Brand A., et al. Pharmacodynamics and pharmacokinetics of carprofen, a non-steroidal anti-inflammatory drug, in healthy cows and cows with Escherichia coli endotoxin-induced mastitis. J Vet Pharmacol Therapeut. 14:1991;219-229
70. Rose D.M., Giri S.N., Cullor J.S., Bushnell R.B. The combined use of lipoxygenase and cyclooxygenase inhibitors in Klebsiella pneumoniae-induced bovine mastitis. Zentralbl Veterinarmed A. 38:(2):1991;99-106
71. Dascanio J.J., Mechor G.D., Grohn Y.T., et al. Effect of phenylbutazone and flunixin meglumine on acute toxic mastitis in dairy cows. Am J Vet Res. 56:1995;1213-1218
72. Green M.J., Green L.E., Cripps P.J. Comparison of fluid and flunixin meglumine therapy in combination and individually in the treatment of toxic mastitis. Vet Rec. 140:1997;149-152